134 related articles for article (PubMed ID: 11960724)
1. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
[TBL] [Abstract][Full Text] [Related]
2. Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
Schaffer M; Schaffer PM; Corti L; Sotti G; Hofstetter A; Jori G; Dühmke E
Onkologie; 2001 Oct; 24(5):482-5. PubMed ID: 11694776
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results.
Schaffer M; Schaffer PM; Jori G; Corti L; Sotti G; Hofstetter A; Dühmke E
Tumori; 2002; 88(5):407-10. PubMed ID: 12487560
[TBL] [Abstract][Full Text] [Related]
4. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
[TBL] [Abstract][Full Text] [Related]
5. Photofrin as a radiosensitizer in an in vitro cell survival assay.
Kulka U; Schaffer M; Siefert A; Schaffer PM; Olsner A; Kasseb K; Hofstetter A; Dühmke E; Jori G
Biochem Biophys Res Commun; 2003 Nov; 311(1):98-103. PubMed ID: 14575700
[TBL] [Abstract][Full Text] [Related]
6. Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer--a report of two cases.
Schaffer M; Schaffer PM; Vogesser M; Ertl-Wagner B; Rauch J; Oberneder R; Jori G; Hofstetter A; Dühmke E
Photochem Photobiol Sci; 2002 Sep; 1(9):686-9. PubMed ID: 12665306
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
8. Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins.
Luksiene Z
Medicina (Kaunas); 2004; 40(9):868-74. PubMed ID: 15456974
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitization of tumours by porphyrins.
Luksiene Z; Juzenas P; Moan J
Cancer Lett; 2006 Apr; 235(1):40-7. PubMed ID: 15946797
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
Schaffer P; Batash R; Ertl-Wagner B; Hofstetter A; Asna N; Schaffer M
Photochem Photobiol Sci; 2019 May; 18(5):1275-1279. PubMed ID: 30892313
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
15. On the double role of photofrin as a photo- and a radio-sensitising agent: a possible new combination therapy for tumours.
Schaffer M; Schaffer PM; Hofstetter A; Dühmke E; Jori G
Photochem Photobiol Sci; 2002 Jun; 1(6):438-9. PubMed ID: 12856714
[No Abstract] [Full Text] [Related]
16. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
[TBL] [Abstract][Full Text] [Related]
17. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
20. Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.
Schaffer M; Hofstetter A; Ertl-Wagner B; Batash R; Pöschl J; Schaffer PM
Strahlenther Onkol; 2013 Nov; 189(11):972-6. PubMed ID: 24158603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
